Literature DB >> 22736914

Animal models for the study of hepatitis C virus infection and replication.

Kristin L MacArthur1, Catherine H Wu, George Y Wu.   

Abstract

Hepatitis C virus (HCV) hepatitis, initially termed non-A, non-B hepatitis, has become one of the leading causes of cirrhosis and hepatocellular carcinoma worldwide. With the help of animal models, our understanding of the virus has grown substantially from the time of initial discovery. There is a paucity of available animal models for the study of HCV, mainly because of the selective susceptibility limited to humans and primates. Recent work has focused modification of animals to permit HCV entry, replication and transmission. In this review, we highlight the currently available models for the study of HCV including chimpanzees, tupaia, mouse and rat models. Discussion will include methods of model design as well as the advantages and disadvantages of each model. Particular focus is dedicated to knowledge of pathophysiologic mechanisms of HCV infection that have been elucidated through animal studies. Research within animal models is critically important to establish a complete understanding of HCV infection, which will ultimately form the basis for future treatments and prevention of disease.

Entities:  

Keywords:  Hepatitis A virus; Hepatitis C virus; Infection; Replication; Vaccine

Mesh:

Year:  2012        PMID: 22736914      PMCID: PMC3380318          DOI: 10.3748/wjg.v18.i23.2909

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application.

Authors:  Norman M Kneteman; Amy J Weiner; John O'Connell; Marc Collett; Tiejun Gao; Lea Aukerman; Rosemary Kovelsky; Zhi-Jie Ni; Qing Zhu; Ahmad Hashash; Janine Kline; Belinda Hsi; Daniel Schiller; Donna Douglas; D Lorne J Tyrrell; David F Mercer
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

3.  Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees.

Authors:  Heidi Barth; Jolanta Rybczynska; Romuald Patient; Youkyung Choi; Ronda K Sapp; Thomas F Baumert; Kris Krawczynski; T Jake Liang
Journal:  Hepatology       Date:  2011-08-11       Impact factor: 17.425

4.  Hepatitis C virus replication in mice with chimeric human livers.

Authors:  D F Mercer; D E Schiller; J F Elliott; D N Douglas; C Hao; A Rinfret; W R Addison; K P Fischer; T A Churchill; J R Lakey; D L Tyrrell; N M Kneteman
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

5.  Transplantation of human hepatocytes into tolerized genetically immunocompetent rats.

Authors:  E C Ouyang; C H Wu; C Walton; K Promrat; G Y Wu
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

6.  Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.

Authors:  Michelina Nascimbeni; Eishiro Mizukoshi; Markus Bosmann; Marian E Major; Kathleen Mihalik; Charles M Rice; Stephen M Feinstone; Barbara Rehermann
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  Non-A, non-B hepatitis-related hepatocellular carcinoma in a chimpanzee.

Authors:  E Muchmore; H Popper; D A Peterson; M F Miller; H M Lieberman
Journal:  J Med Primatol       Date:  1988       Impact factor: 0.667

8.  A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.

Authors:  Antonella Folgori; Stefania Capone; Lionello Ruggeri; Annalisa Meola; Elisabetta Sporeno; Bruno Bruni Ercole; Monica Pezzanera; Rosalba Tafi; Mirko Arcuri; Elena Fattori; Armin Lahm; Alessandra Luzzago; Alessandra Vitelli; Stefano Colloca; Riccardo Cortese; Alfredo Nicosia
Journal:  Nat Med       Date:  2006-02-05       Impact factor: 53.440

9.  Efficient infection of tree shrew (Tupaia belangeri) with hepatitis C virus grown in cell culture or from patient plasma.

Authors:  Xinping Xu; Hongbo Chen; Xiaomei Cao; Kunlong Ben
Journal:  J Gen Virol       Date:  2007-09       Impact factor: 3.891

10.  A novel immunocompetent rat model of HCV infection and hepatitis.

Authors:  George Y Wu; Masayoshi Konishi; Cherie M Walton; Denise Olive; Kazuhiko Hayashi; Catherine H Wu
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

View more
  7 in total

1.  Ultrastructural localization of tyrosine hydroxylase in tree shrew nucleus accumbens core and shell.

Authors:  L A McCollum; R C Roberts
Journal:  Neuroscience       Date:  2014-04-24       Impact factor: 3.590

Review 2.  Mouse models for liver cancer.

Authors:  Latifa Bakiri; Erwin F Wagner
Journal:  Mol Oncol       Date:  2013-02-05       Impact factor: 6.603

Review 3.  Scotomas in molecular virology and epidemiology of hepatitis C virus.

Authors:  Yue Wang
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

Review 4.  Interaction Between the Neglected Tropical Disease Human Schistosomiasis and HCV Infection in Egypt: a Puzzling Relationship.

Authors:  Mahmoud M Bahgat
Journal:  J Clin Transl Hepatol       Date:  2014-06-15

5.  Transient replication of Hepatitis C Virus sub-genomic RNA in murine cell lines is enabled by miR-122 and varies with cell passage.

Authors:  Patricia A Thibault; Joyce A Wilson
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

6.  Identification of glyceraldehyde 3-phosphate dehydrogenase sequence and expression profiles in tree shrew (Tupaia belangeri).

Authors:  Yu Zheng; Qihui Wang; Chenxia Yun; Yingjun Wang; Wanli W Smith; Jing Leng
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

7.  Characterization of hepatitis E virus infection in tree shrew (Tupaia belangeri chinensis).

Authors:  Wenhai Yu; Chenchen Yang; Yanhong Bi; Feiyan Long; Yunlong Li; Jue Wang; Fen Huang
Journal:  BMC Infect Dis       Date:  2016-02-16       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.